PlacidWay teams with Stem Cells Kyron Colombia on regenerative care access

PlacidWay has partnered with Stem Cells Kyron Colombia in Cali to connect international patients with stem cell and regenerative medicine treatments. The deal aims to expand access for Americans and other travelers seeking lower-cost care in Colombia.

Why it matters: - The partnership gives international patients a direct pathway to regenerative medicine in Colombia, where treatment costs can be 50% to 70% lower than comparable protocols in North America. - The collaboration targets growing demand from patients in the U.S., Canada, the Caribbean and nearby South American countries. - Colombia's regulatory environment and clinic infrastructure are drawing more medical travelers to Cali for stem cell therapy.

What happened: - PlacidWay announced a strategic partnership with Stem Cells Kyron Colombia, a regenerative medicine clinic in Cali, Colombia. - The companies said the goal is to streamline access to specialized stem cell therapies for international patients across the Americas. - The announcement was dated Aug. 30, 2026.

The details: - Stem Cells Kyron Colombia operates under Dr. Carlos Rojas, founder and medical director, who has more than 20 years of clinical experience. - The clinic uses high-potency mesenchymal stem cells, exosomes and individualized treatment plans. - Colombia permits the cultivation of mesenchymal stem cells in INVIMA-regulated GMP laboratories. - The clinic offers regenerative protocols for neurological, orthopedic, autoimmune and systemic health needs. - The listed treatment areas include Multiple Sclerosis, traumatic brain injury, spinal cord injuries and autism. - Other areas include osteoarthritis, spine and disc conditions, sports injuries, rheumatoid arthritis, autoimmune diseases and gastrointestinal disorders. - The clinic also markets therapies for chronic pain, sexual wellness and erectile dysfunction, cosmetic care, anti-aging and skin health. - PlacidWay operates as a medical tourism marketplace and Platform as a Service, connecting patients with healthcare providers in more than 60 countries. - PlacidWay's platform includes medical education and secure communication tools for patients and providers before travel. - The company also said the platform helps patients compare treatment claims and access specialized care. - PlacidWay shared social media links at LinkedIn, Bluesky, Instagram, Facebook, YouTube, TikTok and X.

Between the lines: - The partnership blends medical travel marketing with a treatment category that is often difficult for patients to evaluate from afar. - PlacidWay's digital intake and education tools appear designed to reduce friction for cross-border care decisions. - Colombia is positioning itself as a lower-cost alternative to North American regenerative medicine markets.

What's next: - The partnership is expected to channel more international patients toward Stem Cells Kyron Colombia. - PlacidWay said the collaboration will help patients make informed decisions before traveling. - Continued demand from American and regional patients could further strengthen Cali's role as a regenerative medicine destination.